Skip to main content
AML: Postremission clonal hematopoiesis persists even after therapies but has little clinical significance
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
AML: Postremission clonal hematopoiesis persists even after therapies but has little clinical significance
User login
Username
Password
Reset your password
Concept
Lead
score
Acute Leukemia
1
0.92
Acute Myeloblastic Leukemia
0
0.72
Cancer
0
0.49
Chemotherapy
0
0.49
Stem Cell Research and Therapy
0
0.4
Texas
0
0.32
Blood
0
0.16
Fellowship
0
0.16
Grant
0
0.16
Leukemia
0
0.16
Remission
0
0.16
Transplantation
0
0.16
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
1
Pharmacist
0
0.89
Transplantation
0
0.45
Med Students
0
0.17
Edit Tags